Thomas Hudson
Chief Tech/Sci/R&D Officer chez ABBVIE INC.
Fortune : 20 M $ au 31/03/2024
Profil
Fondateur de l'Université McGill et du Centre d'innovation Gnome Qubec, Thomas J. Hudson est Chief Scientific Officer, Senior VP-R&D chez AbbVie, Inc. Il est également directeur scientifique du Consortium P3G et professeur à l'Université de Toronto. Dans le passé, il a été président et directeur scientifique de l'Institut ontarien de recherche sur le cancer, directeur adjoint du Centre de recherche sur le génome de l'Institut Whitehead de recherche biomédicale et directeur de l'Université McGill et du Centre d'innovation Gnome Qubec.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABBVIE, INC.
0,01% | 28/02/2024 | 107 267 ( 0,01% ) | 20 M $ | 31/03/2024 |
Postes actifs de Thomas Hudson
| Sociétés | Poste | Début |
|---|---|---|
| ABBVIE INC. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| University of Toronto | Corporate Officer/Principal | 01/01/2007 |
| P3G Consortium | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Thomas Hudson
| Sociétés | Poste | Fin |
|---|---|---|
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | President | 01/01/2016 |
| McGill University & Génome Québec Innovation Centre | Founder | 01/01/2011 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2001 |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Formation de Thomas Hudson
| University of Montréal | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
| P3G Consortium |
